Association between sarcopenia and physical function among preoperative lung cancer patients
- Authors
- Kong, S.[Kong, S.]; Shin, S.[Shin, S.]; Lee, J.K.[Lee, J.K.]; Lee, G.[Lee, G.]; Kang, D.[Kang, D.]; Cho, J.[Cho, J.]; Kim, H.K.[Kim, H.K.]; Zo, J.I.[Zo, J.I.]; Shim, Y.M.[Shim, Y.M.]; Park, H.Y.[Park, H.Y.]; Shin, D.W.[Shin, D.W.]
- Issue Date
- Dec-2020
- Publisher
- MDPI AG
- Keywords
- Cardiopulmonary function; Lung cancer; Muscle strength; Physical activity; Preoperative; Sarcopenia; Skeletal muscle mass
- Citation
- Journal of Personalized Medicine, v.10, no.4, pp.1 - 11
- Indexed
- SCIE
SCOPUS
- Journal Title
- Journal of Personalized Medicine
- Volume
- 10
- Number
- 4
- Start Page
- 1
- End Page
- 11
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/6489
- DOI
- 10.3390/jpm10040166
- ISSN
- 2075-4426
- Abstract
- We aimed to investigate the prevalence of sarcopenia using new diagnostic criteria and association of sarcopenia with cardiopulmonary function and physical activity (PA) in preoperative lung cancer patients. The data of 614 patients were obtained from the CATCH-LUNG cohort study. Patients were classified into three groups—normal (n = 520), pre-sarcopenia (n = 60, low skeletal muscle mass index only), and sarcopenia (n = 34, low SMI and strength). Cardiopulmonary function was measured using the 6-min walk test (6MWT), and PA was objectively measured using a wearable device. The adjusted odds ratio (aOR) for a <400-m distance in 6MWT was 3.52 (95% confidence interval (CI) 1.34–9.21) and 6.63 (95% CI 2.25–19.60) in the pre-sarcopenia and sarcopenia groups, respectively, compared to that in the normal group. The aOR (95% CI) for <5000 steps/day was 1.64 (0.65–4.16) and 4.20 (1.55–11.38) in the pre-sarcopenia and sarcopenia groups, respectively, compared to that in the normal group. In conclusion, the prevalence of pre-sarcopenia and sarcopenia was 9.8% and 5.5%, respectively, among preoperative lung cancer patients. Cardiopulmonary function and physical activity were significantly lower in the pre-sarcopenia and sarcopenia groups than in the normal group. Patients with sarcopenia had more robust findings, suggesting the importance of muscle strength and mass. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/6489)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.